Celeris Therapeutics

Tech-enabled early-stage drug discovery companyCeleris Therapeutics is a tech-enabled early-stage drug discovery company that uses innovative, computer-based methods to develop degrader drugs for currently undruggable pathogenic proteins that are related to Parkinson's, various types of cancers, and other diseases.CelerisTx announces $4.4m financing to advance pipeline of nove…www.biospace.com/art...